Plant Biotechnology Market Growth 2035
Here are Plant Biotechnology Market insights with company references and quantitative values that you can use for market research, reports, or presentations.
Plant Biotechnology Market – Key Insights with Company References
Market Overview
Global market size: ~USD 52.0 billion in 2025, projected to reach USD 158.6 billion by 2035, growing at ~7.9% CAGR (2026–2035).
Major players include **Bayer AG, Corteva Agriscience, Syngenta Group, BASF SE, UPL Limited, and FMC Corporation.
https://www.fiormarkets.com/report/plant-biotechnology-market-size-by-product-type-transgenic-420611.html
1. Recent Developments
BASF SE expanded its agricultural biotechnology portfolio by investing 9–10% of its agriculture revenue into R&D for seeds and pest-resistant crop development.
Bayer AG is leveraging relaxed European gene-edited crop regulations to accelerate development of gene-edited wheat and nitrogen-efficient crops.
Corteva Agriscience generates ~USD 17 billion annual sales, largely from biotech seeds and crop protection technologies used globally.
In 2026, biotech collaborations such as the ATGC Biotech–Luxembourg Industries JV launched new sustainable crop protection platforms.
2. Market Drivers
1. Rising demand for higher agricultural productivity
GM seeds and traits improve crop yields by 10–25% in major crops like corn and soybean (widely commercialized by **Bayer AG and Corteva Agriscience).
2. Growing food security concerns
Global population projected to reach ~9.7 billion by 2050, increasing pressure on crop production.
3. Climate-resilient crops
Companies like Syngenta Group and BASF SE are developing drought- and pest-resistant seeds.
4. Adoption of genome editing technologies
CRISPR-Cas9 tools allow faster trait improvement and cost reduction in crop breeding.
3. Market Restraints
Regulatory challenges
Strict GMO regulations in regions such as Europe delay commercialization of biotech crops.
High R&D costs
Developing a genetically modified crop may cost USD 100–150 million and take 10–12 years.
Public perception issues
Consumer concerns about GMO foods affect adoption in several markets.
Intellectual property barriers
Patents and licensing agreements restrict smaller biotech firms.
4. Regional Segmentation Analysis
North America
Holds ~41% market share due to high adoption of GM crops and strong R&D infrastructure.
Major companies: Corteva Agriscience, FMC Corporation.
Europe
Strong research ecosystem including institutes and companies like BASF SE.
Asia-Pacific
Fastest growth due to increasing biotech crop cultivation in China, India, and Southeast Asia.
Latin America
Brazil and Argentina are major adopters of GM soybean and maize.
5. Emerging Trends
Genome editing technologies
Rapid adoption of CRISPR-based crop breeding programs.
AI-driven crop improvement
AI is used to identify genetic traits that improve yield and disease resistance.
Synthetic biology
Companies such as Evogene Ltd. and Indigo Ag are developing bio-engineered crop inputs.
Biological crop protection
Increased shift toward microbial and biological pesticides.
6. Top Use Cases
Genetically Modified (GM) Crops
Insect-resistant maize and herbicide-tolerant soybean.
Crop Trait Development
Drought-resistant wheat and rice.
Biofuel Production
Modified crops used for ethanol and bioenergy production.
Nutrient-fortified crops
Biofortified rice and maize with enhanced vitamins.
Industrial biotechnology
Plant-based production of enzymes and pharmaceuticals.
7. Major Challenges
Regulatory approval delays for genetically engineered crops.
Environmental concerns regarding biodiversity and gene transfer.
Supply chain issues for biotech seeds.
Resistance development in pests due to prolonged GMO crop usage.
8. Attractive Opportunities
Emerging markets expansion
Asia-Pacific biotech agriculture market expected to grow fastest.
Climate-smart agriculture
Development of heat- and drought-tolerant crops.
Biotech seed commercialization
Biotech seeds already represent ~65% of plant biotechnology product revenue.
Synthetic biology crops
Used for bio-chemicals and high-value plant compounds.
9. Key Factors of Market Expansion
Increasing global food demand and shrinking arable land.
Technological advancements in genome editing and molecular breeding.
Heavy R&D investments by major agritech companies.
Rising adoption of sustainable agriculture practices.
Growth of biotech seed and trait technologies in commercial farming.
✅ If you want, I can also prepare a “Top 10 Plant Biotechnology Companies with revenue + market share” table or a short 150–200 word analyst-style summary (perfect for reports or LinkedIn posts).
Here are Plant Biotechnology Market insights with company references and quantitative values that you can use for market research, reports, or presentations.
Plant Biotechnology Market – Key Insights with Company References
Market Overview
Global market size: ~USD 52.0 billion in 2025, projected to reach USD 158.6 billion by 2035, growing at ~7.9% CAGR (2026–2035).
Major players include **Bayer AG, Corteva Agriscience, Syngenta Group, BASF SE, UPL Limited, and FMC Corporation.
https://www.fiormarkets.com/report/plant-biotechnology-market-size-by-product-type-transgenic-420611.html
1. Recent Developments
BASF SE expanded its agricultural biotechnology portfolio by investing 9–10% of its agriculture revenue into R&D for seeds and pest-resistant crop development.
Bayer AG is leveraging relaxed European gene-edited crop regulations to accelerate development of gene-edited wheat and nitrogen-efficient crops.
Corteva Agriscience generates ~USD 17 billion annual sales, largely from biotech seeds and crop protection technologies used globally.
In 2026, biotech collaborations such as the ATGC Biotech–Luxembourg Industries JV launched new sustainable crop protection platforms.
2. Market Drivers
1. Rising demand for higher agricultural productivity
GM seeds and traits improve crop yields by 10–25% in major crops like corn and soybean (widely commercialized by **Bayer AG and Corteva Agriscience).
2. Growing food security concerns
Global population projected to reach ~9.7 billion by 2050, increasing pressure on crop production.
3. Climate-resilient crops
Companies like Syngenta Group and BASF SE are developing drought- and pest-resistant seeds.
4. Adoption of genome editing technologies
CRISPR-Cas9 tools allow faster trait improvement and cost reduction in crop breeding.
3. Market Restraints
Regulatory challenges
Strict GMO regulations in regions such as Europe delay commercialization of biotech crops.
High R&D costs
Developing a genetically modified crop may cost USD 100–150 million and take 10–12 years.
Public perception issues
Consumer concerns about GMO foods affect adoption in several markets.
Intellectual property barriers
Patents and licensing agreements restrict smaller biotech firms.
4. Regional Segmentation Analysis
North America
Holds ~41% market share due to high adoption of GM crops and strong R&D infrastructure.
Major companies: Corteva Agriscience, FMC Corporation.
Europe
Strong research ecosystem including institutes and companies like BASF SE.
Asia-Pacific
Fastest growth due to increasing biotech crop cultivation in China, India, and Southeast Asia.
Latin America
Brazil and Argentina are major adopters of GM soybean and maize.
5. Emerging Trends
Genome editing technologies
Rapid adoption of CRISPR-based crop breeding programs.
AI-driven crop improvement
AI is used to identify genetic traits that improve yield and disease resistance.
Synthetic biology
Companies such as Evogene Ltd. and Indigo Ag are developing bio-engineered crop inputs.
Biological crop protection
Increased shift toward microbial and biological pesticides.
6. Top Use Cases
Genetically Modified (GM) Crops
Insect-resistant maize and herbicide-tolerant soybean.
Crop Trait Development
Drought-resistant wheat and rice.
Biofuel Production
Modified crops used for ethanol and bioenergy production.
Nutrient-fortified crops
Biofortified rice and maize with enhanced vitamins.
Industrial biotechnology
Plant-based production of enzymes and pharmaceuticals.
7. Major Challenges
Regulatory approval delays for genetically engineered crops.
Environmental concerns regarding biodiversity and gene transfer.
Supply chain issues for biotech seeds.
Resistance development in pests due to prolonged GMO crop usage.
8. Attractive Opportunities
Emerging markets expansion
Asia-Pacific biotech agriculture market expected to grow fastest.
Climate-smart agriculture
Development of heat- and drought-tolerant crops.
Biotech seed commercialization
Biotech seeds already represent ~65% of plant biotechnology product revenue.
Synthetic biology crops
Used for bio-chemicals and high-value plant compounds.
9. Key Factors of Market Expansion
Increasing global food demand and shrinking arable land.
Technological advancements in genome editing and molecular breeding.
Heavy R&D investments by major agritech companies.
Rising adoption of sustainable agriculture practices.
Growth of biotech seed and trait technologies in commercial farming.
✅ If you want, I can also prepare a “Top 10 Plant Biotechnology Companies with revenue + market share” table or a short 150–200 word analyst-style summary (perfect for reports or LinkedIn posts).
Plant Biotechnology Market Growth 2035
Here are Plant Biotechnology Market insights with company references and quantitative values that you can use for market research, reports, or presentations.
Plant Biotechnology Market – Key Insights with Company References
Market Overview
Global market size: ~USD 52.0 billion in 2025, projected to reach USD 158.6 billion by 2035, growing at ~7.9% CAGR (2026–2035).
Major players include **Bayer AG, Corteva Agriscience, Syngenta Group, BASF SE, UPL Limited, and FMC Corporation.
https://www.fiormarkets.com/report/plant-biotechnology-market-size-by-product-type-transgenic-420611.html
1. Recent Developments
BASF SE expanded its agricultural biotechnology portfolio by investing 9–10% of its agriculture revenue into R&D for seeds and pest-resistant crop development.
Bayer AG is leveraging relaxed European gene-edited crop regulations to accelerate development of gene-edited wheat and nitrogen-efficient crops.
Corteva Agriscience generates ~USD 17 billion annual sales, largely from biotech seeds and crop protection technologies used globally.
In 2026, biotech collaborations such as the ATGC Biotech–Luxembourg Industries JV launched new sustainable crop protection platforms.
2. Market Drivers
1. Rising demand for higher agricultural productivity
GM seeds and traits improve crop yields by 10–25% in major crops like corn and soybean (widely commercialized by **Bayer AG and Corteva Agriscience).
2. Growing food security concerns
Global population projected to reach ~9.7 billion by 2050, increasing pressure on crop production.
3. Climate-resilient crops
Companies like Syngenta Group and BASF SE are developing drought- and pest-resistant seeds.
4. Adoption of genome editing technologies
CRISPR-Cas9 tools allow faster trait improvement and cost reduction in crop breeding.
3. Market Restraints
Regulatory challenges
Strict GMO regulations in regions such as Europe delay commercialization of biotech crops.
High R&D costs
Developing a genetically modified crop may cost USD 100–150 million and take 10–12 years.
Public perception issues
Consumer concerns about GMO foods affect adoption in several markets.
Intellectual property barriers
Patents and licensing agreements restrict smaller biotech firms.
4. Regional Segmentation Analysis
North America
Holds ~41% market share due to high adoption of GM crops and strong R&D infrastructure.
Major companies: Corteva Agriscience, FMC Corporation.
Europe
Strong research ecosystem including institutes and companies like BASF SE.
Asia-Pacific
Fastest growth due to increasing biotech crop cultivation in China, India, and Southeast Asia.
Latin America
Brazil and Argentina are major adopters of GM soybean and maize.
5. Emerging Trends
Genome editing technologies
Rapid adoption of CRISPR-based crop breeding programs.
AI-driven crop improvement
AI is used to identify genetic traits that improve yield and disease resistance.
Synthetic biology
Companies such as Evogene Ltd. and Indigo Ag are developing bio-engineered crop inputs.
Biological crop protection
Increased shift toward microbial and biological pesticides.
6. Top Use Cases
Genetically Modified (GM) Crops
Insect-resistant maize and herbicide-tolerant soybean.
Crop Trait Development
Drought-resistant wheat and rice.
Biofuel Production
Modified crops used for ethanol and bioenergy production.
Nutrient-fortified crops
Biofortified rice and maize with enhanced vitamins.
Industrial biotechnology
Plant-based production of enzymes and pharmaceuticals.
7. Major Challenges
Regulatory approval delays for genetically engineered crops.
Environmental concerns regarding biodiversity and gene transfer.
Supply chain issues for biotech seeds.
Resistance development in pests due to prolonged GMO crop usage.
8. Attractive Opportunities
Emerging markets expansion
Asia-Pacific biotech agriculture market expected to grow fastest.
Climate-smart agriculture
Development of heat- and drought-tolerant crops.
Biotech seed commercialization
Biotech seeds already represent ~65% of plant biotechnology product revenue.
Synthetic biology crops
Used for bio-chemicals and high-value plant compounds.
9. Key Factors of Market Expansion
Increasing global food demand and shrinking arable land.
Technological advancements in genome editing and molecular breeding.
Heavy R&D investments by major agritech companies.
Rising adoption of sustainable agriculture practices.
Growth of biotech seed and trait technologies in commercial farming.
✅ If you want, I can also prepare a “Top 10 Plant Biotechnology Companies with revenue + market share” table or a short 150–200 word analyst-style summary (perfect for reports or LinkedIn posts).
0 Comments
0 Shares